New Hope for People Battling With Depression | Bloomberg Businessweek

Описание: Compass Pathways is a mental health care company developing new treatments for people who haven’t responded to existing medications and continue to struggle with their mental health. The company was the first to report successful Phase 3 clinical trial results for a psychedelic treatment, known as COMP360 psilocybin, for treatment-resistant depression (TRD) and is positioned to potentially be the first to receive regulatory approval and bring a psychedelic-based medicine to market.

Kabir Nath, the CEO of Compass Pathways, details his company's path building a scalable, safe, and accessible psychedelic care system and model. Kabir speaks with Carol Massar and Alexis Christoforous on Bloomberg Businessweek Daily.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.


Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts
Listen to more of Bloomberg Businessweek:    • Bloomberg Businessweek  

#Bloomberg #Podcast #News #Businessweek

Visit us: https://www.bloomberg.com/podcasts

Follow Bloomberg Podcasts on Twitter:   / podcasts  

Visit our other YouTube channels:
Bloomberg Television:    / @markets  
Bloomberg Originals:    / bloomberg  
Quicktake:    / @bloombergquicktake  

For coverage on news, markets and more: http://www.bloomberg.com/video